Derek Lowe's commentary on drug discovery and the pharma industry. An editorially independent blog from the publishers of Science Translational Medicine. All content is Derek’s own, and he does not in any way speak for his employer.
You know, we’re all mutants. No, not just those of us reading (or writing!) this web site, I mean all of us. We all have regions of our genome that are highly variable, of course – the sequences (often based on number of repeat markers) that are used in forensic DNA analysis or the mitochondrial… Read More
With all the work going into targeted protein degradation now (recent review), we’re discovering a lot of things about it that weren’t apparent at first. To pick an obvious one, these things have several steps in their mechanism (binding to the target protein, binding to a ubiquitin ligase to form a ternary complex, ubiquitination of… Read More
So we have the first prize of the 2019 Nobel season, Medicine/Physiology for William Kaelin Jr. (Dana-Farber), Peter Ratcliffe (Oxford), and Gregg Semenza (Johns Hopkins), for their work in cellular adaptation to oxygen levels. This was not one of the outcomes that was in the top of the betting range, but it sure wasn’t in the… Read More
I’ve highlighted several articles here over the years that cast doubt (to say the least) on the popular belief that Antioxidants Are Always Good For You. These other views do not seem to have penetrated the public consciousness yet, though, to judge by the way that foods and supplements are advertised. Today brings another example… Read More
Layer upon layer! That’s what cell biology provides you with – just when you think you understand some area of it, things turn out to be more complex. I’m going on in this mode after looking over this new preprint from the Bertozzi lab at Stanford, which uncovers a new class of biomolecules that no… Read More
OK, today’s blog post is going to be even weirder than usual – we’re going to wander off into quantum mechanics. And into a particular borderland of it where have been a lot of interesting hypotheses and speculations, but plenty of hand-waving hoo-hah, so it’s important to realize the risks up front. But here we go. Read More
As many will know, there is a whole set of what are termed “polyglutamine repeat disorders“, which themselves are a large part of a bigger set of trinucleotide repeat disorders. Huntington’s disease is a well-known one: the gene (HTT) for the huntingtin protein ends up with a series of CAG nucleotide repeats, which after translati… Read More
OK, let’s get reductionist, and let’s see why getting reductionist often works so well. How do you know when your finger has touched something? You feel it – but how do you feel it? Your nerves have sent an impulse to your brain, which interprets it as something having physically come into contact with your… Read More
Well, it’s inadvertently been sort of a Neuroscience Week here. This latest paper is a very interesting addition to the field indeed, just out from a very large team centered at the Allen Institute, where some rather large-scale work in the field has been done in the past. This one continues their tradition: it’s a… Read More
When you look closely at cellular biochemistry, what you see are a lot of amazing processes that are surrounded by amazing amounts of redundancy, backups, patches, and accumulated tweaks and fixes. That’s evolution for you; these things have been piling up for a billion years or two, and we’re all the descendants of the critters… Read More
